Symbol="CVAC"
AssetType="Common Stock"
Name="CureVac NV"
Description="CureVac NV, a clinical-stage biopharmaceutical company, is focused on developing various transformative drugs based on messenger ribonucleic acid (mRNA). The company is headquartered in Tbingen, Germany."
CIK="1809122"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="PAUL-EHRLICH-STRABE 15 TUBINGEN, BADEN-WURTTEMBERG, DE"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="1936320000"
EBITDA="-226372992"
PERatio="None"
PEGRatio="None"
BookValue="3.187"
DividendPerShare="0"
DividendYield="0"
EPS="-1.63"
RevenuePerShareTTM="0.257"
ProfitMargin="0"
OperatingMarginTTM="-4.781"
ReturnOnAssetsTTM="-0.15"
ReturnOnEquityTTM="-0.42"
RevenueTTM="50176000"
GrossProfitTTM="-91549000"
DilutedEPSTTM="-1.63"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.708"
AnalystTargetPrice="15.8"
TrailingPE="-"
ForwardPE="9.17"
PriceToSalesRatioTTM="13.29"
PriceToBookRatio="2.071"
EVToRevenue="8.61"
EVToEBITDA="-8.89"
Beta="2.781"
num_52WeekHigh="12.79"
num_52WeekLow="5.63"
num_50DayMovingAverage="9.82"
num_200DayMovingAverage="8.58"
SharesOutstanding="223852000"
DividendDate="None"
ExDividendDate="None"
symbol="CVAC"
open="8.50"
high="9.03"
low="8.50"
price="8.91"
volume="364140.00"
latest_trading_day="2023-08-18"
previous_close="8.65"
change="0.26"
change_percent="3.0058%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="36"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="64"
Volume_recent_avg="581289"
Change_recent_avg="0.02"
Delta_recent_avg="0.57"
Variance_recent_avg="0.28"
Change_ratio_recent_avg="0.19"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="64"
Aroon_momentum_negative="36"
image_negative_thumbnail_id_1="1111"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0144.jpeg"
image_negative_thumbnail_id_2="101"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0075.jpeg"
image_neutral_thumbnail_id_1="551"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0048.jpeg"
image_neutral_thumbnail_id_2="538"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0061.jpeg"
image_positive_thumbnail_id_1="697"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0011.jpeg"
image_positive_thumbnail_id_2="602"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0106.jpeg"
image_professor_thumbnail_id_1="1179"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0013.jpeg"
image_professor_thumbnail_id_2="1174"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0008.jpeg"
